Literature DB >> 5794247

Effect of heparin on the inactivation of serum lipoprotein lipase by the liver in unanesthetized dogs.

T F Whayne, J M Felts, P A Harris.   

Abstract

The injection of heparin into the circulation produces a rapid increase in circulating serum lipoprotein lipase. The lipolysis system apparently circulates as a heparin-apoenzyme complex. Lipoprotein lipase activity disappears from the circulation in an exponential fashion. Available evidence suggests that a major site of removal of lipoprotein lipase activity is the liver. We have evaluated the efficiency of the inactivation system in catheterized unanesthetized dogs by studying the portal vein-hepatic vein difference in lipoprotein lipase activity. Our results demonstrate the high efficiency of the inactivation system in vivo. The results of this study also show that high levels of heparin can block the inactivation system and suggest a possible two-step mechanism. The first step in inactivation may involve the destruction of heparin by a liver heparinase. This step may induce dissociation of the active complex. After dissociation, the apoenzyme is apparently removed in a second step.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5794247      PMCID: PMC322346          DOI: 10.1172/JCI106089

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  IMPORTANCE OF LIVER IN RELEASE AND DEGRADATION OF LIPOPROTEIN LIPASE.

Authors:  R E CONDON; H TOBIAS; D V DATTA
Journal:  Surg Forum       Date:  1964

2.  THE LIVER AND POSTHEPARIN PLASMA LIPOLYTIC ACTIVITY IN DOG AND MAN.

Authors:  R E CONDON; H TOBIAS; D V DATTA
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

3.  Kinetic studies on metabolism of lipoprotein lipase.

Authors:  Y YOSHITOSHI; C NAITO; H OKANIWA; M USUI; T MOGAMI; T TOMONO
Journal:  J Clin Invest       Date:  1963-05       Impact factor: 14.808

4.  The production of lipolytic activity in the circulation of the hind limb in response to heparin.

Authors:  D S ROBINSON; P M HARRIS
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1959-01

5.  Lipoprotein lipase response in Laennec's cirrhosis.

Authors:  S P BAKER; H LEVINE; L TURNER; A DUBIN
Journal:  Proc Soc Exp Biol Med       Date:  1958-12

6.  Role of liver and kidney in development of heparin-induced lipemia clearing activity.

Authors:  P CONSTANTINIDES; Y SO; F R JOHNSTONE
Journal:  Proc Soc Exp Biol Med       Date:  1959-02

7.  Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart.

Authors:  E D KORN
Journal:  J Biol Chem       Date:  1955-07       Impact factor: 5.157

8.  Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil.

Authors:  E D KORN
Journal:  J Biol Chem       Date:  1955-07       Impact factor: 5.157

9.  Removal of postheparin plasma "lipoprotein lipase" by the normal and diseased liver.

Authors:  D V Datta
Journal:  Gastroenterology       Date:  1965-11       Impact factor: 22.682

10.  The mechanism of low postheparin plasma lipolytic activity (PHLA) in patients with cirrhosis of the liver.

Authors:  D V Datta
Journal:  J Lab Clin Med       Date:  1966-03
View more
  2 in total

1.  Acute pancreatitis with hyperlipemia: the incidence of lipid abnormalities in acute pancreatitis.

Authors:  J L Cameron; D M Capuzzi; G D Zuidema; S Margolis
Journal:  Ann Surg       Date:  1973-04       Impact factor: 12.969

2.  Incidence and Management of Hypertriglyceridemia-Associated Acute Pancreatitis: A Prospective Case Series in a Single Australian Tertiary Centre.

Authors:  Hong Lin Evelyn Tan; Georgina McDonald; Alexander Payne; William Yu; Zahrul Ismadi; Huy Tran; Jon Gani; Katie Wynne
Journal:  J Clin Med       Date:  2020-12-06       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.